LinkOPH

LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation reports second quarter 2015 financial results and operational highlights

Read more →

MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today provided a corporate update for the second quarter of 2015. “During the quarter, we made significant progress across multiple aspects of our business, most notably towards the initiation of a Phase 2 study in dry AMD and a pivotal study in SMD,” said Paul K. Wotton, Ph.D., President and Chief Executive Officer. “In addition, the completion of our financing ha

Read more →

Aerie Pharmaceuticals and GrayBug announced a partnership and licensing agreement to collaborate on delivery technologies for Aerie’s ophthalmic treatment candidates, according to an Aerie news release. The collaboration includes an exclusive option for Aerie to license GrayBug technology to develop and commercialize sustained-release versions of Aerie’s ophthalmic products, according to the release.

Read more →

A hydrophobic acrylic IOL with heparin coating reduced flare 1 day postoperatively but did not reduce posterior capsule opacification more than an uncoated version of the same lens at 1 year, a study found.The prospective study included 102 eyes of 51 …

Read more →

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/mcgdx8/allergic) has announced the addition of the “Allergic Conjunctivitis-Pipeline Insights” report to their offering. Allergic Conjunctivitis- Pipeline Insight…

Read more →

The European Society of Ophthalmology is contributing to the development of strategies to implement fellowships across continental Europe and gradually harmonize subspecialty training.The results of the European Board of Ophthalmology (EBO) Surgical Sk…

Read more →